Benign Böbrek Tümörleri

Yazarlar

Selim Taş

Özet

Günümüzde görüntüleme yöntemlerinin yaygınlaşmasıyla benign böbrek tümörlerinin tanısı artmıştır. En sık izlenen kitleler olan basit böbrek kistleri genellikle asemptomatiktir ve malignite riskini belirlemek için Boşniak sınıflandırması kullanılır. Klinik semptomu olmayan Boşniak I-II kistlerine müdahale gerekmezken, ileri evrelerde cerrahi veya takip tercih edilir. İyi huylu heterojen tümörler olan anjiyomiyolipomlar (AML); düz kas, kan damarı ve yağ dokusundan oluşur; sporadik veya tüberoskleroz kompleksiyle ilişkili gelişebilir. AML yönetiminde aktif gözlem, embolizasyon, ablasyon veya mTOR inhibitörleri kullanılır. Katı kitlelerin önemli bir kısmını oluşturan renal onkositomlar genellikle iyi huyludur, ancak preoperatif olarak renal hücreli karsinomdan (RHK) ayırt edilmeleri zordur ve kesin tanı biyopsi veya cerrahiyle konur. Düz kas hücrelerinden köken alan nadir mezenkimal tümörler olan leiomyomlar ile ilkel metanefrik tübüler hücrelerden oluşan metanefrik adenomlar da genellikle asemptomatiktir. Her iki tümörün ayırıcı tanısında immünohistokimyasal paneller ve radyolojik yöntemler kullanılsa da kesin tanı cerrahiyle konur. Boyutu 4 cm'den küçük iyi huylu solid kitlelerde parsiyel nefrektomi, büyüklerde ise radikal nefrektomi standart tedavi seçeneğidir.

With the widespread use of imaging modalities today, the diagnosis of incidental benign renal tumors has increased. Simple renal cysts, the most frequently observed benign masses, are generally asymptomatic, and the Bosniak classification is utilized to determine their malignancy risk and guide management. While no intervention is required for asymptomatic Bosniak I and II cysts, regular follow-up or surgical interventions are performed for higher categories. Angiomyolipomas (AMLs) are benign, heterogeneous neoplasms consisting of smooth muscle, blood vessels, and adipose tissue, which can occur sporadically or in association with tuberous sclerosis complex. The management of AMLs includes active surveillance, selective embolization, ablation, or mTOR inhibitors depending on the risk of life-threatening hemorrhage. Renal oncocytomas constitute a significant portion of solid renal masses; they are mostly benign but difficult to differentiate preoperatively from renal cell carcinoma (RCC), requiring percutaneous biopsy or surgery for a definitive diagnosis. Renal leiomyomas, rare mesenchymal neoplasms originating from smooth muscle cells, and metanephric adenomas, composed of primitive metanephric tubular cells, are also generally asymptomatic and incidentally identified. Although immunohistochemical profiles and advanced radiological assessments help differentiate these masses from malignant counterparts, definitive diagnoses are established through surgery, where partial nephrectomy is preferred for tumors smaller than 4 cm and radical nephrectomy is indicated for larger masses.

Referanslar

Terada N, Arai Y, Kinukawa N, Terai A. The 10- year natural history of simple renal cysts. Urology 2008; 71: 7-12.

Chang CC, Kuo JY, Chan WL, et al. Prevalence and clinical characteristics of simple renal cysts. J Chin Med Assoc 2007; 70: 486-91

Porpiglia F, Fiori C, Billia M, et al. Retroperitoneal decortication of simple renal cysts vs decortication with wadding using perirenal fat tissue: results of a prospective randomized trial. BJU Int 2009; 103: 1532-6.

Vaidyanathan S, Hughes PL, Oo T, Soni BM. Spontaneous rupture of an infected renal cyst and external drainage through a lumbar surgical scar in a male patient with cervical spinal cord injury: a case report. J Med Case Rep 2008; 14; 2: 154.

Bosniak M.A. The current radiological approach to renal cysts. Radiology. 1986;158:1–10. doi: 10.1148/radiology.158.1.3510019.

Edney E., Davenport M.S., Curci N.,et al. Pedrosa I. Bosniak classification of cystic renal masses, version 2019: Interpretation pitfalls and recommendations to avoid misclassification. Abdom. Radiol. 2021;46:2699–2711. doi: 10.1007/s00261-020-02906-8.

Schieda N., Davenport M.S., Krishna S.,et al. Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. Radiographics. 2022;42:E33. doi: 10.1148/rg.219016.

Silverman S.G., Pedrosa I., Ellis J.H., et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology. 2019;292:475–488. doi: 10.1148/radiol.2019182646.

Terada N, Arai Y, Kinukawa N, Yoshimura K, Terai A. Risk factors for renal cysts. BJU Int 2004;93: 1300-1302.

Bosniak MA. Problems in the radiologic diagnosis of renal parenchymal tumors. Urol Clin North Am 1993;20(2):217–230.

Ascenti G, Mazziotti S, Zimbaro G, et al. Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 2007;243(1):158–165.

Sevcenco S., Spick C., Helbich T.H.,et al. P.A. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography—A systematic review and meta-analysis. Eur. Radiol. 2017;27:2239–2247. doi: 10.1007/s00330-016-4631-9.

Schoots I.G., Zaccai K., Hunink M.G.,et al. Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review. J. Urol. 2017;198:12–21. doi: 10.1016/j.juro.2016.09.160.

Israel G.M., Bosniak M.A. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF) AJR Am. J. Roentgenol. 2003;181:627–633. doi: 10.2214/ajr.181.3.1810627.

Flum, AS, Hamoui, N, Said, MA, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2017; 195(4): 834–846. DOI: 10.1016/j.juro.2015.07.126.

Jinzaki, M, Silverman, SG, Akita, H, et al. Renal angiomyolipoma: A radiological classification and update on recent developments in diagnosis and management. Abdom Imaging. 2014; 39(3): 588–604. DOI: 10.1007/s00261-014-0083-3.

Lane, BR, Aydin, H, Danforth, TL, et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: Classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008; 180(3): 836–843. DOI: 10.1016/j.juro.2008.05.041.

Fittschen, A, Wendlik, I, Oeztuerk, S, et al. Prevalence of sporadic renal angiomyolipoma: A retrospective analysis of 61,389 in- and out-patients. Abdom Imaging. 2014; 39(5): 1009–1013. DOI: 10.1007/s00261-014-0129-6.

Halpenny, D, Snow, A, McNeill, G et al. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol. 2010; 65(2): 99–108. DOI: 10.1016/j.crad.2009.09.014.

Logue, LG, Acker, RE and Sienko, AE. Best cases from the AFIP: Angiomyolipomas in tuberous sclerosis. Radiographics. 2003; 23(1): 241–246. DOI: 10.1148/rg.231025109.

Jinzaki, M, Silverman, SG, Akita, H, et al. Diagnosis of renal angiomyolipomas: Classic, Fat-Poor, and Epithelioid types. Semin Ultrasound CT MR. 2017; 38(1): 37–46. DOI: 10.1053/j.sult.2016.11.001.

Johnson, SR, Taveira-DaSilva, AM and Moss, J. Lymphangioleiomyomatosis. Clin Chest Med. 2016; 37(3): 389–403. DOI: 10.1016/j.ccm.2016.04.002.

von Ranke, FM, Faria, IM, Zanetti, et al. E. Imaging of tuberous sclerosis complex: A pictorial review. Radiol Bras. 2017; 50(1): 48–54. DOI: 10.1590/0100-3984.2016.0020.

Pirson, Y. Tuberous sclerosis complex-associated kidney angiomyolipoma: From contemplation to action. Nephrol Dial Transplant. 2013; 28(7): 1680–1685. DOI: 10.1093/ndt/gft009.

Sahni, VA and Silverman, ST. Biopsy of renal masses: When and why. Cancer Imaging. 2009; 9(1): 44–55. DOI: 10.1102/1470-7330.2009.0005.

Kiefer, RM and Stavropoulos, SW. The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas. Curr Urol Rep. 2017; 18(5): 36 DOI: 10.1007/s11934-017-0687-6.

Potretzke, AM, Potretzke, TA, Bauman, TM, et al. Computed Tomography and Magnetic Resonance Findings of Fat-Poor Angiomyolipomas. J Endourol. 2017; 31(2): 119–128. DOI: 10.1089/end.2016.0219.

Jeon, HG, Lee, SR, Kim, KH, et al. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: Prevalence and predictors in Korean patients. Urology. 2017; 76(3): 574–579. DOI: 10.1016/j.urology.2009.11.082.

Yang, CW, Shen, SH, Chang, YH, et al. Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? AJR Am J Roentgenol. 2013; 201(5): 1017–1028. DOI: 10.2214/AJR.12.10204.

Maclean, DFW, Sultana, R, Radwan, R, McKnight,et al. Is the follow-up of small renal angiomyolipomas a necessary precaution? Clin Radiol. 69(8): 822–826. DOI: 10.1016/j.crad.2014.03.016.

Murray, TE, Doyle, F and Lee, M. Transarterial Embolization of Angiomyolipoma: A Systematic Review. J Urol. 2017; 194(3): 635–639. DOI: 10.1016/j.juro.2015.04.081.

Seyam, RM, Alkhudair, WK, Kattan, SA, et al. The Risks of Renal Angiomyolipoma: Reviewing the evidence. J Kidney Cancer VHL. 2017; 4(4): 13–25. DOI: 10.15586/jkcvhl.2017.97.

Prevoo, W, van den Bosch, MAAJ and Horenblas, S. Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology. 2017; 72(1): 188–191. DOI: 10.1016/j.urology.2008.02.059.

Makki, A, Graumann, O, Søren, S, et al. J Endourol. 2017; 31(11): 1117–1122. DOI: 10.1089/end.2017.0376.

Bissler, JJ and Kingswood, JC. Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: A systematic review. Ther Adv Urol. 2016; 8(4): 279–290. DOI: 10.1177/1756287216641353.

Coombs, EJ. Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas. J Am Assoc Nurse Pract. 2013; 25(11): 588–596. DOI: 10.1002/2327-6924.12081.

Morra MN, Das S: Renal oncocytoma: a review of histogenesis, histopathology, diagnosis and treatment. J Urol. 1993, 150:295-302. 10.1016/s0022-5347(17)35466-6.

Tryggvason G, Jónsson E, Gudjónsson H,et al. Bilateral multifocal renal oncocytoma--a case report and literature review. Scand J Urol Nephrol. 2001, 35:150-2. 10.1080/003655901750170623.

Phillips JL, Pavlovich CP, Walther M, et al.The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy. Curr Opin Urol 2001; 11:463-9.

Zbar B, Lerman M: Inherited carcinomas of the kidney. Adv Cancer Res 1998; 75:163-201.

Alamara C, Karapanagiotou EM, Tourkantonis I, et al.: Renal oncocytoma: a case report and short review of the literature. Eur J Intern Med. 2008, 19:e67-9. 10.1016/j.ejim.2008.03.003.

Dechet, C. B., Sebo, T., Farrow, G., et al. "Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults." The Journal of urology 162.4 (1999): 1282-1284.

Amin, M. B., Crotty, T. B., Tickoo, S. K., et al. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. The American journal of surgical pathology, 1997, 21.1: 1-12.

Licht, M. R., Novick, A. C., Tubbs, R. R., Klein, E. A., Levin, H. S., & Streem, S. B. (1993). Renal oncocytoma: clinical and biological correlates. The Journal of urology, 150(5), 1380-1383.

Romis L, Cindolo L, Patard JJ, Messina G, Altieri V, Salomon L, Abbou CC, Chopin D, Lobel B and de La Taille A: Frequency, clinical presentation and evolution of renal oncocytomas: Multicentric experience from a European database. Eur Urol. 45:53–57; discussion 57. 2004.

Dechet CB, Bostwick DG, Blute ML, Bryant SC and Zincke H: Renal oncocytoma: Multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol. 162:40–42. 1999.

Kuroda N, Inoue Y, Taguchi T, Tominaga A, Hes O, Michal M, et al. Renal leiomyoma: An immunohistochemical, ultrastructural and comparative genomic hybridization study. Histology and Histopathology. 2007;22:883–88.

Protzel C, Woenckhaus C, Zimmermann U, Klebingat KJ. Leiomyoma of the kidney. Differential diagnostic aspects of renal cell carcinoma with increasing clinical relevance. Urologe A. 2001;40:384–87.

Yusim IE, Neulander EZ, Eidelberg I, Lismer LJ, Kaneti J. Leiomyoma of the genitourinary tract. Scand J Urol. 2001;35:295–99.

Nagar AM, Raut AA, Narlawar RS, Bhatgadde VL, Rege S, Thapar V. Giant renal capsular leiomyoma: study of two cases. British Journal of Radiology. 2004;77:957–58.

Katabathina VS, Vikram R, Nagar AM, Tamboli P, Menias CO, Prasad SR. Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics. 2010;30:1525–40.

Eugenio Brunocilla, Cristian Vincenzo Pultrone, Riccardo Schiavina, Valerio Vagnoni, Giacoma Caprara, Giuseppe Martorana. Renal leiomyoma: Case report and literature review. Canadian Urological Association Journal. 2012;6:87–90.

Nakib G, Mahgoub N, Calcaterra V, Pelizzo G (2017) Renal leiomyoma in pediatric age: a rare case report with review of the literature. J PediatrSurg Case Rep 27:43–46.

Brunocilla E, Pultrone C, Schiavina R, Vagnoni V, Caprara G, Martorana G (2012) Renal leiomyoma: case report and literature review. Can UrolAssoc J 6(2):E87-90.

Goren MR, Erbay G, Ozer C, Goren V, Bal N, Bilateral renal leiomyoma with 5 year follow-up: Case report Can Urol Assoc J 2015 9(9-10):E734-E736.

Hogan A, Smyth GK, D’Arcy C, O’Brien A, Quinlan DM, Renal capsular leiomyoma Urology 2008 71:1226.e1-1226.e3.

Khetrapal S, Bhargava A, Jetley S, Rana S, Jairajpuri Z, Renal leiomyoma: an uncommon differential diagnosis of renal masses with a clinical relevance JCDR 2014 8(10):FD08-FD09.

Renshaw AA, Freyer DR, Hammers YA. Metastatic metanephric adenoma in a child. Am J Surg Pathol. 2000;24(4):570–4.

Davis CJ, Jr, Barton JH, Sesterhenn IA, et al. Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol. 1995;19:1101–1114.

Argani P. Metanephric neoplasms: the hyperdifferentiated, benign end of the Wilms tumor spectrum? Clin Lab Med. 2005;25:379–392.

Mantoan Padilha M, Billis A, Allende D, et al. Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features. Histopathology. 2013;62:941–953.

Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison. Am J Surg Pathol. 2001;25:1290–1296.

Olgac S, Hutchinson B, Tickoo SK, et al. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol. 2006;19:218–224.

Choueiri TK, Cheville J, Palescandolo E, et al. BRAF mutations in metanephric adenoma of the kidney. Eur Urol. 2012;62:917–922.

Zhang LJ, Yang GF, Shen W, Lu GM: CT and ultrasound findings of metanephric adenoma: a report of two cases and literature review. Br J Radiol 2011; 84:e51-54.

Helenon O, Eiss D, Debrito P, Merran S, Correas JM: How to characterise a solid renal mass: a new classification proposal for a simplified approach. Diagn Interv Imaging 2012; 93:232-45.

Yayınlanan

6 Ocak 2023

Lisans

Lisans